Travelers (TRV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Besides Wall Street's top -and-bottom-line estimates for Vail Resorts (MTN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended April 2025.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Victoria's Secret (VSCO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Ciena (CIEN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for DocuSign (DOCU), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Lululemon (LULU), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=151260&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151261&wire=1&utm_campaign=5 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Strategy Incorporated (NASDAQ:MSTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/strategy-incorporated-lawsuit-submission-form?prid=151257&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your NET Power, Inc. (NYSE:NPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/net-power-inc-lawsuit-submission-form?prid=151258&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.

Strategic Evolution Enhances Service Excellence Beyond U.S. Borders with Direct Access to International Markets NEW YORK , June 2, 2025 /PRNewswire/ -- Douglas Elliman Inc. (NYSE: DOUG), one of the largest residential real estate brokerages with the highest national average sales price, today announced the launch of Elliman International, extending the company's renowned and exacting service to key global markets. This strategic initiative will enable Douglas Elliman to directly serve its agents, clients, and developers' growing international real estate needs without limited third-party intermediaries.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151259&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=151262&wire=1&utm_campaign=29 or contact Joseph E.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

PayPal's turnaround is gaining traction, with improved transaction margins, strong operating leverage, and a successful rollout of upgraded checkout experiences driving higher conversion rates. PayPal's Q1 FY25 saw a significant EPS beat, driven by 7-8% transaction margin growth outpacing revenue, marking its fifth consecutive quarter of profitable expansion. The upgraded online branded checkout, now at >45% US traffic, boosts conversion by 100bps, promising substantial TPV, revenue, and margin growth ahead.

PARIS & NEW YORK & SINGAPORE--(BUSINESS WIRE)--The Generation Essentials Group (“TGE”) and Black Spade Acquisition II Co (NASDAQ: BSII) (“Black Spade II”) announced that their previously proposed business combination (the “Business Combination”) was approved at an extraordinary general meeting of Black Spade II's shareholders on May 30, 2025. The Business Combination is expected to close on June 3, 2025. Upon closing, TGE will become the publicly traded entity, with its Class A ordinary shares.

Eliminating transaction fees and enabling $100 investments highlights the inclusive evolution of modern investing platforms.

NEW YORK & NOIDA, India--(BUSINESS WIRE)-- #AI--HCLTech and UiPath today announced a strategic partnership to accelerate agentic automation for UiPath customers globally.

Unlike its big brother, Broadcom NASDAQ: AVGO, custom chip maker Marvell Technology NASDAQ: MRVL has yet to participate much in the recent recovery among semiconductor stocks. This became even more true after the company's latest earnings, which failed to inspire investors.